AGF Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

AGF Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Buy	+12,200	New	+$2.67M	0.01%	409
2024 Q4	–	Sell	-26,892	Closed	-$3M	–	714
2024 Q3	$3M	Buy	+26,892	New	+$2.95M	0.02%	445
2023 Q3	–	Sell	-27,018	Closed	-$3.35M	–	751
2023 Q2	$3.35M	Buy	27,018 +3,457	+15%	+$465K	0.02%	408
2023 Q1	$3.45M	Buy	23,561 +2,022	+9%	+$299K	0.02%	351
2022 Q4	$3.43M	Buy	+21,539	New	+$3.16M	0.02%	348

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AGF Management's JAZZ Position: Q2 2026 in Review

AGF Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 12,200 shares worth $2.94M. The stake represents 0.01% of the portfolio and ranks #409 among its holdings. This is a return to the name: AGF Management previously reported a position in JAZZ as recently as Q3 2024.

AGF Management first reported a position in JAZZ in Q4 2022 and has held it in 5 quarters since. The position peaked at $3.45M in Q1 2023. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

AGF Management held 12,200 shares of Jazz Pharmaceuticals worth $2.94M as of Q2 2026.
Jazz Pharmaceuticals was a new AGF Management position in Q2 2026.
Jazz Pharmaceuticals made up 0.01% of AGF Management's portfolio in Q2 2026, its #409 holding.
AGF Management first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
AGF Management's Jazz Pharmaceuticals position peaked at $3.45M in Q1 2023.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.